All News

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalys…

Roche is set to pay out a little more than $1 billion to acquire digital pathology specialist Path AI in a mov…

Today's guest post comes from George Moore, Chief Product and Technology Officer at CareMetx. George argues th…

Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease dru…

Even though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta's e…

Plus, news about BioCryst, GSK and Roche. 🙃 Entrada’s Duchenne drug disappoints: The biotech reported initial…

A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newslet…

Sales and profit should shrink less than originally anticipated thanks to strong momentum for its new obesity …

Deal volume in 2026 is far outpacing last year, and is being driven by cancer and autoimmune disease drugs.…

Following a series of “most favored nation” pricing deals with 17 large pharma companies, the Trump administra…

GSK has found another potential way to treat cardiometabolic disease with a modality close to the pharma’s hea…

The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1…

At least two drugmakers say they’re feeling the impact of the Inflation Reduction Act, after the first drug pr…

Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana…

This page displays an interactive map of the current status of state decisions on the Affordable Care Act's Me…

Knoa Pharma will still sell the opioid medications that triggered a national crisis, but with guardrails.…

This brief reviews the case now before the Supreme Court, Louisiana v. FDA, and provides an overview of the ot…

Amid the growing use of artificial intelligence (AI) in the claims review cycle, this brief discusses the type…

The U.S. Supreme Court has temporarily reinstated online access to the abortion pill mifepristone after a fede…

Madrigal Pharmaceuticals has struck a backloaded deal for the global license to an Arrowhead Pharmaceuticals p…

MSD has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of treatments for chronic m…